Study to Evaluate Efficacy, Safety, Tolerability, and Pharmacodynamics of Entospletinib in Adults With Relapsed or Refractory Hematologic Malignancies
Clinical trial NCT01799889 · TERMINATED
Trial details
- NCT number
- NCT01799889
- Sponsor
- Gilead Sciences
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-03-14
- Primary completion
- 2017-09-14
- Enrollment
- 326
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.